Updates

Craneware - Second downgrade this year

August 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Craneware, a supplier of billing and auditing software to US hospitals, has warned that although it has identified a large number of opportunities it hasn't closed any further deals. It therefore expects to report revenues of US$41m (2011: US$38.1m) and EBITDA 15% higher (2011: US$10.1m) than last year but below market expectations. The problem has been that US hospitals are more focused on delivering Electronics Health Records in order to receive incentive payments from the US regulator and Craneware's sales cycles have lengthened as a result. Broker N+1 Brewin has downgraded eps forecasts for the year just ended from 30.7 cents to 26.4 cents (17p) with current year forecasts downgraded from 39.2 to 32.2 cents (21p). While ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Greene King - Shares hit three-year high

Synergy Health - Acquisition opens doorgrade to huge US market

Craneware (September 2013)

Craneware (November 2012)

Craneware (March 2012)

Craneware (November 2011)

Craneware - New contract wins (September 2011)

Craneware - Acquistion raises forecasts (April 2011)

Craneware - Another amazing share price spike (December 2010)

Craneware - Shares spike vertically by over Â£1 (October 2010)

Craneware (June 2010)

Craneware - Billing software firm enjoying quick-fire growth (February 2010)

Craneware - Billing software firm sees huge US healthcare opportunity (October 2008)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X